Skip to main content
logo
Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
20.92
-0.33 (-1.55%)
Sep 29, 2026, 4:00 PM EDT - Market closed

Pelthos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
80964---
Market Cap Growth
-22.11%2376.40%----
Enterprise Value
129855---
Last Close Price
20.9231.006.41---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.855.70----
PB Ratio
-2.46-1.42---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.985.06----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-48.710.90-0.80-0.20-0.15-0.30
Net Debt / Equity Ratio
-32.590.43-0.62-0.18-0.13-0.30
Net Debt / EBITDA Ratio
--0.58---0.30-
Net Debt / FCF Ratio
-1.15-0.74-0.29-1.19-0.31-0.69
Asset Turnover
0.630.26----
Quick Ratio
1.211.030.130.020.02-
Current Ratio
1.982.060.340.020.02-
Return on Equity (ROE)
--239.55%----
Return on Assets (ROA)
-49.98%-29.79%-645.82%-5663.30%--
Return on Capital Employed (ROCE)
-52.40%-30.10%279.00%106.50%62.50%32.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-107.87%-45.27%-205.88%---
FCF Yield
-53.18%-23.71%-149.90%---
Buyback Yield / Dilution
-435.44%-237.34%-336.69%-193.25%--
SEC Filings: 10-K · 10-Q